More answers like this
GPT-5Oct 28, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Leans yes
Short answer: Blanket pauses on all AI work are a blunt tool. A better approach is targeted, enforceable restrictions on the highest‑risk activities, paired with strong safety standards, audits, and incident response. Temporary pauses should be used when concrete risk thresholds are exceeded or when safeguards aren’t in place.
Why not a blanket pause
•Costs: would stall useful advances (medicine, accessibility, climate, security) and entrench dominant firms via compliance fixed costs.
•Evasion: pushes work to less regulated jurisdictions; hard to coordinate globally.
•Feasibility: “AI” is too broad—most applications are low risk.
Where restrictions or time‑boxed pauses make sense
•Training or deploying “frontier” models above defined compute/capability thresholds when safety cases aren’t met.
•Systems showing dangerous capabilities in evals (e.g., scalable cyber‑offense, deception/autonomy, detailed biological design).
•Uses in critical infrastructure, biometric mass surveillance, or high‑stakes decisions (health, finance, law enforcement) without robust oversight.
•Releasing raw model weights for dual‑use capabilities (e.g., advanced bio/cyber design) absent containment and monitoring plans.
•After serious incidents or near‑misses until root causes are fixed (with public post‑mortems).
What to restrict and how (risk‑tiered)
•Licenses for high‑compute training runs: require pre‑registration, safety plans, and independent audits before training and deployment.
•Capability evaluations: standardized, adversarial red‑teaming for bio/cyber/autonomy risks; deployment gates tied to passing scores.
•Responsible release: staged/API‑first access, rate limits, fine‑grained permissions; withhold weights for red‑tier models.
•Data governance: ban training on unlawfully obtained data; require privacy/copyright compliance and data‑risk assessments.
•Traceability: content provenance/watermarking for generative media; secure logging for forensic review.
•Incident response: mandatory reporting, kill‑switches, rollback plans, and recall authority for regulators.
•Liability and insurance: allocate responsibility for foreseeable harms; require reserves or coverage for red‑tier deployments.
•Compute and supply‑chain controls: report large compute purchases; safeguards in accelerators for usage logging; targeted export controls for the most capable chips.
Open source and research
•Encourage open methods/evals/datasets for low/medium‑risk areas.
•For high‑risk capabilities, separate openness of research from distribution of powerful weights; support vetted researcher access in secure sandboxes.
International coordination
•Align on thresholds, evals, and audit standards; share incident data.
•Narrow, enforceable agreements (bio/cyber safeguards; chip exports; model registration) rather than broad, vague pledges.
A practical policy frame (stoplight)
•Green: low‑risk applications (recommendation, productivity tools) → general safety practices, no special license.
•Yellow: medium‑risk (health/finance decision support) → certification, human oversight, logs, evaluations.
•Red: frontier training and dual‑use capabilities → licenses, independent audits, gated access, and pause authority if gates aren’t met.
Bottom line
•Don’t pause everything; do pause or restrict specific high‑risk activities until safety criteria are satisfied.
•Make restrictions precise, testable, and enforceable, so innovation in low‑risk areas continues while society keeps leverage over the riskiest edges.
If you tell me your context (policy memo, debate prep, product governance, or a specific domain like healthcare or education), I can tailor a concrete checklist and talking points.